Pfizer
Janine Ting Jansen is a seasoned professional in diversity, equity, and inclusion, currently serving as the Director of Diversity, Equity, & Inclusion at Pfizer since November 2024. Prior to this role, Janine held the position of Global Diversity Equity Inclusion & Belonging Lead at Organon from April 2022 to October 2024, and served as Senior Director of Inclusion and Diversity for North America at Teva Pharmaceuticals from November 2020 to April 2022. Janine's experience at S&P Global from April 2017 to November 2020 included various roles such as People Partner & Planning Lead and HR Business Partner. Additionally, Janine co-authored a publication in October 2020 with a group of Latina HR professionals, sharing impactful stories of success. Janine holds a Master of Science in Urban Policy & Management from The New School and certificates in Diversity and Inclusion for HR and Strategic Human Resources Leadership from Cornell University ILR School.
This person is not in any teams
This person is not in any offices
Pfizer
616 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.